Samuel Bjork
Board Director
![](https://t-therapeutics.com/wp-content/uploads/2023/10/t-cell-bind-300x61.png)
![](https://t-therapeutics.com/wp-content/uploads/2023/11/Sam_Bjork.jpg)
Samuel is a Partner at Digitalis Ventures. Prior to Digitalis, Samuel was a member of the healthcare and clean energy practices at the Boston Consulting Group.
He received graduate degrees from Cambridge and Oxford University as a Marshall Scholar and an A.B. in Chemistry from Harvard University
![](https://t-therapeutics.com/wp-content/uploads/2023/10/T-Therapeutics_icon-footer-150x150.png)